Market Overview:
The global Biofermin market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type, application and region. By type, the market is segmented into tablets, powdery and other. By application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies. The North American region dominates the global Biofermin market followed by Europe and Asia Pacific respectively. Some of the key players in this market are Pfizer Inc., GlaxoSmithKline plc., Merck & Co., Inc., Johnson & Johnson Services Inc., Sanofi S.
Product Definition:
Biofermin is a protein that is found in the blood and helps to carry iron. It is important for transporting oxygen throughout the body.
Tablets:
Biofermin is a complex mixture of vitamins and proteins. It is used as an iron supplement for infants and children suffering from hemoglobinopathies. Biofermin has the ability to improve the oxygen carrying capacity of blood by increasing its hemoglobin content, which makes it effective in treating anemia caused due to chronic diseases such as sickle cell disease, thalassemia or lead poisoning.
Powdery:
Powdery mildew is a fungal disease that affects cereals and other crops. It is caused by a fungus, rust or smut which belongs to the genus Sclerotia. The disease has three stages namely; infection, development and completed stage wherein the infected plant parts show symptoms of powdery white mycelium (fungus) on them.
Application Insights:
The global biofermin market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is expected to witness the highest growth over the forecast period owing to increasing internet usage for purchasing medicines. Biofermin tablets are available in various forms such as film-coated tablets & strips, effervescent tablet & powder and others which can be used for different purposes by mixing it with water or other liquids.
Online pharmaceutical companies offer free home delivery of medicines which has increased the adoption of e-pharmacies across countries including India, China, Australia among others have been conducting surveys on a regular basis regarding this matter. According to one survey conducted in 2017 by OnePoll nearly two thirds (65%) of people aged 18¢â‚¬â€œ24 years purchased their medicines through an e-pharmacy while half (50%) purchased them from a local pharmacy [8].
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biofermin manufacturers and suppliers coupled with high healthcare expenditure, favorable reimbursement policies, and increasing patient awareness levels are some factors driving the regional demand. In addition, growing concerns regarding drug-resistant infections have led to an increase in the consumption of antibiotics which is expected to further fuel growth over the forecast period.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising disposable income leading to increased demand for pharmaceuticals among patients as well as health professionals. Moreover, improving healthcare infrastructure along with rising patient awareness about antibiotic alternatives will also drive regional product demand over next eight years. Increasing incidence of multi-drug resistant tuberculosis has led governments across countries such as India and China for instance are focusing on promoting alternative treatment options such as antimicrobial drugs that target bacteria rather than treating diseases caused by them which is expected boost market growth during forecast period 8% annually).
Growth Factors:
- Increasing demand for bio-based products: The global market for bio-based products is expected to grow at a CAGR of more than 14% from 2016 to 2021. This growth can be attributed to the increasing awareness about the benefits of using bio-based products, which are environment-friendly and sustainable.
- Rising demand from end users: The end users of biofermin include food and beverage manufacturers, pharmaceutical companies, and cosmetics manufacturers. Biofermin is used as an additive in various food items such as breads, cakes, cookies, etc., to improve their nutritional value. It is also used in the production of nutraceuticals and cosmeceuticals products.
- Growing research and development activities: The key players in the biofermin market are investing heavily in research and development activities to develop new applications for this product. For instance, Inbiose NV (Belgium), a leading player in the biotechnology sector, has developed a novel process that uses enzymes derived from bacteria to produce high quality ferulic acid from wheat bran fiber residues obtained during milling operations . This could open up new opportunities for application of ferulic acid across different industries such as food & beverage processing , nutraceuticals , personal care , etc .
Scope Of The Report
Report Attributes
Report Details
Report Title
Biofermin Market Research Report
By Type
Tablets, Powdery, Other
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Guilin Pharmaceutical, Sinoway Pharmaceutical, Hebei Huanhai Pharmaceutical, Hebei Tianyuan Pharmaceutical, Shandong Baiwei Pharmaceutical, Huibei Widely Chemical Technology, Okobaike Biotechnology, Taisho
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Biofermin Market Report Segments:
The global Biofermin market is segmented on the basis of:
Types
Tablets, Powdery, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guilin Pharmaceutical
- Sinoway Pharmaceutical
- Hebei Huanhai Pharmaceutical
- Hebei Tianyuan Pharmaceutical
- Shandong Baiwei Pharmaceutical
- Huibei Widely Chemical Technology
- Okobaike Biotechnology
- Taisho
Highlights of The Biofermin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Powdery
- Other
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biofermin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biofermin is a natural product that has been shown to have anti-inflammatory and antioxidant properties. It is also known to improve blood circulation and reduce the risk of heart disease.
Some of the major players in the biofermin market are Guilin Pharmaceutical, Sinoway Pharmaceutical, Hebei Huanhai Pharmaceutical, Hebei Tianyuan Pharmaceutical, Shandong Baiwei Pharmaceutical, Huibei Widely Chemical Technology, Okobaike Biotechnology, Taisho.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biofermin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biofermin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biofermin Market - Supply Chain
4.5. Global Biofermin Market Forecast
4.5.1. Biofermin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biofermin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biofermin Market Absolute $ Opportunity
5. Global Biofermin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biofermin Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Powdery
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biofermin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biofermin Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biofermin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biofermin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biofermin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biofermin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biofermin Demand Share Forecast, 2019-2026
9. North America Biofermin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biofermin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biofermin Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biofermin Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Powdery
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biofermin Demand Share Forecast, 2019-2026
10. Latin America Biofermin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biofermin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biofermin Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biofermin Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Powdery
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biofermin Demand Share Forecast, 2019-2026
11. Europe Biofermin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biofermin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biofermin Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biofermin Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Powdery
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biofermin Demand Share, 2019-2026
12. Asia Pacific Biofermin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biofermin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biofermin Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biofermin Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Powdery
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biofermin Demand Share, 2019-2026
13. Middle East & Africa Biofermin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biofermin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biofermin Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biofermin Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Powdery
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biofermin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Biofermin Market: Market Share Analysis
14.2. Biofermin Distributors and Customers
14.3. Biofermin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Guilin Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sinoway Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hebei Huanhai Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hebei Tianyuan Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Shandong Baiwei Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Huibei Widely Chemical Technology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Okobaike Biotechnology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Taisho
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
